见贤思齐
Lv7
5000 积分
2021-08-12 加入
-
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
18天前
已关闭
-
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
19天前
已完结
-
Investigating the effect of immunonutrition on patients with gastrointestinal cancer receiving adjuvant chemotherapy
23天前
已关闭
-
The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study
1个月前
已完结
-
慢性鼻窦炎诊断和治疗指南(2024)
2个月前
已完结
-
[Guidelines for the diagnosis and optimal management of asthma in children (2025)]
2个月前
已完结
-
Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
3个月前
已完结
-
Real-World Evidence of Clinical Outcomes in Precision Radionuclide Oncology: The NIGHTCAP Study of 177Lu-PSMA in Metastatic Prostate Cancer
3个月前
已完结
-
前列腺癌规范化标本取材及病理诊断共识(2021版)
3个月前
已完结
-
Efficacy and tolerance of a diabetes specific formula in patients with type 2 diabetes mellitus: An open label, randomized, crossover study
3个月前
已完结